Structural Formula (Image 1)
Estradiol Cream
Product Images NDC 50090-3327
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Estradiol (NDC 50090-3327). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Table 1 (Image 2)
The text appears to be a table of data presenting the results of a study, displaying the absolute risk and confidence intervals of various events occurring in a group of women over a certain period of time. The events recorded include coronary heart disease, stroke, breast cancer, fractures, and mortality, among others. The table also indicates the number of women affected by each event. The study appears to have been conducted by the WHI and lasted for an average of 7.1 years.*
Table 2 (Image 3)
The text appears to be a table showing the results of a study comparing the effects of CEMPA vs Placebo on different health outcomes in women, including events related to cardiovascular disease, cancer, fractures, and mortality. The table includes estimates of absolute risk per 10,000 women-years for various events, as well as 95% confidence intervals. The results are based on centrally adjudicated data and adapted from publications of the Women's Health Initiative. The table notes that confidence intervals are nominal and unadjusted for multiple comparisons. Some outcomes are not included in the "global index", which is a combination of specific events.*
Label Image (Lbl500903327)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
